[HTML][HTML] Predictors of exacerbations in chronic obstructive pulmonary disease-results from the Bergen COPD cohort study
GR Husebø, PS Bakke, M Aanerud, JA Hardie… - PloS one, 2014 - journals.plos.org
Background COPD exacerbations accelerate disease progression. Aims To examine if
COPD characteristics and systemic inflammatory markers predict the risk for acute COPD …
COPD characteristics and systemic inflammatory markers predict the risk for acute COPD …
Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD
GR Husebø, R Grønseth, L Lerner… - European …, 2017 - Eur Respiratory Soc
… Author contributions: GR Husebø, JA Hardie, PS Bakke and TM Eagan designed the study.
… GR Husebø and TM Eagan analysed the data and drafted the manuscript. All authors have …
… GR Husebø and TM Eagan analysed the data and drafted the manuscript. All authors have …
Coagulation markers as predictors for clinical events in COPD
GR Husebø, EC Gabazza… - …, 2021 - Wiley Online Library
… exerts opposing effects under conditions of low-grade and high-grade thrombin generation.
Under conditions of low-grade thrombin generation, thrombin binds to thrombomodulin to …
Under conditions of low-grade thrombin generation, thrombin binds to thrombomodulin to …
[HTML][HTML] The pulmonary mycobiome—A study of subjects with and without chronic obstructive pulmonary disease
…, TML Eagan, EO Leiten, I Haaland, GR Husebø… - PloS one, 2021 - journals.plos.org
Background The fungal part of the pulmonary microbiome (mycobiome) is understudied. We
report the composition of the oral and pulmonary mycobiome in participants with COPD …
report the composition of the oral and pulmonary mycobiome in participants with COPD …
[HTML][HTML] Risk factors for lung cancer in COPD–results from the Bergen COPD cohort study
GR Husebø, R Nielsen, J Hardie, PS Bakke… - Respiratory …, 2019 - Elsevier
Background COPD patients have an increased risk of developing lung cancer, but the underlying
mechanisms are poorly understood. We aimed to identify risk factors for lung cancer in …
mechanisms are poorly understood. We aimed to identify risk factors for lung cancer in …
Protected sampling is preferable in bronchoscopic studies of the airway microbiome
…, HG Wiker, S Tangedal, Y Xue, GR Husebø… - ERJ Open …, 2017 - Eur Respiratory Soc
The aim was to evaluate susceptibility of oropharyngeal contamination with various
bronchoscopic sampling techniques. 67 patients with obstructive lung disease and 58 control …
bronchoscopic sampling techniques. 67 patients with obstructive lung disease and 58 control …
The airway microbiota and exacerbations of COPD
…, C Drengenes, S Tangedal, GR Husebø… - ERJ Open …, 2020 - Eur Respiratory Soc
Aim The aim of this study was to investigate whether the compositionality of the lower
airway microbiota predicts later exacerbation risk in persons with COPD in a cohort study. …
airway microbiota predicts later exacerbation risk in persons with COPD in a cohort study. …
Macrophage migration inhibitory factor, a role in COPD
GR Husebø, PS Bakke, R Grønseth… - … of Physiology-Lung …, 2016 - journals.physiology.org
Macrophage migration inhibitor factor (MIF) is a pluripotent cytokine associated with several
different inflammatory conditions, but its role within lung inflammation and chronic …
different inflammatory conditions, but its role within lung inflammation and chronic …
[HTML][HTML] A longitudinal study of the pulmonary mycobiome in subjects with and without chronic obstructive pulmonary disease
…, TML Eagan, HG Wiker, EO Leiten, GR Husebø… - Plos one, 2022 - journals.plos.org
Background Few studies have examined the stability of the pulmonary mycobiome. We
report longitudinal changes in the oral and pulmonary mycobiome of participants with and …
report longitudinal changes in the oral and pulmonary mycobiome of participants with and …
Complications and discomfort after research bronchoscopy in the MicroCOPD study
…, E Nordeide, GR Husebø… - BMJ open …, 2020 - bmjopenrespres.bmj.com
Background Data on discomfort and complications from research bronchoscopy in chronic
obstructive pulmonary disease (COPD) and asthma is limited. We present complications and …
obstructive pulmonary disease (COPD) and asthma is limited. We present complications and …